Use of the bleeding time in the neonatal intensive care unit

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 91, Issue 438, 2002, Pages 82-86

  Del Vecchio, A ^a  

^a Azienda Ospedaliera Di Summa   (Italy)

Author keywords

Bleeding time; Neonates; Platelet dysfunction; Primary hemostasis

Indexed keywords

IBUPROFEN; INDOMETACIN; PENICILLIN DERIVATIVE; THEOPHYLLINE; VON WILLEBRAND FACTOR;

ANAMNESIS; BLEEDING DISORDER; BLEEDING TIME; BLOOD CLOTTING TEST; CONFERENCE PAPER; DEVICE; DIAGNOSTIC VALUE; ERYTHROCYTE VOLUME; GESTATIONAL AGE; HEMATOCRIT; HEMOSTASIS; HUMAN; MATERNAL DISEASE; MICROANGIOPATHY; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THROMBOCYTE DISORDER; THROMBOCYTE FUNCTION;

BLEEDING TIME; BLOOD COAGULATION DISORDERS; BLOOD PLATELET DISORDERS; FEMALE; HEMORRHAGIC DISORDERS; HEMOSTASIS; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; PLATELET FUNCTION TESTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0036429828     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Andrew M, Brooker LA. Hemostatic disorders in newborns. In: Taeusch HW, Ballard RA, editors. Avery's Diseases of the Newborn. 7th Ed. Philadelphia, PA: WB Saunders; 1998
2. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12:95-104
3. Sola MC, Christensen RD. Developmental aspects of platelets and disorders of platelets in the neonatal period. In: Christensen RD, editor. Hematologic Problems of the Neonate. 1st Ed. Philadelphia, PA: WB Saunders; 1999
4. Kühne T, Imbach P. Neonatal platelet physiology and pathophysiology. Eur J Pediatr 1998; 157: 87-94
5. Sola MC, Del Vecchio A, Rimsza LM. Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Clin Perinatol 2000; 27: 655-79
6. Blanchette VS, Rand ML. Platelet disorders in newborn infants: Diagnosis and management. Semin Perinatol 1997; 21: 53-62
7. Dykes FD, Lazzara A, Ahmann P, Blumenstein B, Schwartz J, Brann AW. Intraventricular hemorrhage: A prospective evaluation of etiopathogenesis. Pediatrics 1980; 66: 42-9
8. Andrew M, Castle V, Mitchell L, Paes B. Modified bleeding time in the infant. Am J Hematol 1989; 30: 190-1
9. Andrew M, Paes B, Bowker J. Evaluation of an automated bleeding time device in the newborn. Am J Hematol 1990; 35: 275-7
10. Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972; 287: 155-9
11. Del Vecchio A, Sola MC. Performing and interpreting the bleeding time in the neonatal intensive care unit. Clin Perinatol 2000; 27: 643-54
12. 2 with the length of the bleeding time. Clin Invest Med 1989; 12: 165-71
13. Gatti L, Guarneri D, Caccamo ML, Gianotti GA, Marini A. Platelet activation in newborns detected by flow cytometry. Biol Neonate 1996; 70: 322-7
14. Sutor AH. The bleeding time in pediatrics. Semin Thromb Hemost 1998; 24: 531-43
15. Del Vecchio A, Sola MC, Presta G, Rosati E, Stronati M, Gasparini C, et al. Factors affecting the template bleeding time in preterm neonates. Pediatr Res 2001; 49: 2: 310
16. Fernandez F, Goudable G, Sie P, Ton-That H, Durand D, Suc JM, et al. Low hematocrit and prolonged bleeding time in uraemic patients: Effect of red cell transfusions. Br J Haematol 1985; 59: 139-48
17. Maurer HM, Caul J. Influence of bilirubin on human platelets. Pediatr Res 1972; 6: 84
18. Friedman Z, Lamberth EL, Jr, Stahlman MT, Oates JA. Platelet dysfunction in the neonate with essential fatty acid deficiency. J Pediatr 1977; 90: 439-43
19. Corazza MS, Davis RF, Merritt TA, Bejar R, Cvetnic W. Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosus. J Pediatr 1984; 105: 292-6
20. Del Vecchio A, Sullivan SE, Christensen RD, Schibler K, Hutson AD, Chevuru SC, et al. Indomethacin prolongs the bleeding time in neonates significantly more than ibuprofen. Pediatr Res 2002; 51: 466A
21. Corby DG, Schulman I. The effects of antenatal drug administration on aggregation of platelets of newborn infants. J Pediatr 1971; 79: 307-13
22. George TN, Johnson KJ, Bates JN, Segar JL. The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr 1998; 132: 731-4
23. Maurer HM, Haggins JC, Still WJS. Platelet injury during phototherapy. Am J Hematol 1976; 1: 89-96
24. Robinson TM, Kickler TS, Walker LK, Ness P, Bell W. Effect of extracorporeal membrane oxygenation on platelets in newborns. Crit Care Med 1993; 21: 1029-34
25. Boneou B, Fernandez F. The role of the hematocrit in bleeding. Transfus Med Rev 1987; 1: 182-5
26. Small M, Lowe GDO, Cameron E, Forbes CD. Contribution of the hematocrit to the bleeding time. Haemostasis 1983; 13: 379-84
27. Sola MC, Del Vecchio A, Edwards TJ, Suttner D, Hutson AD, Christensen RD. The relationship between hematocrit and bleeding time in very low birth weight infants during the first week of life. J Perinatol 2001; 21: 368-71
28. Alkhamis TM, Beissinger RL, Chediak JR. Artificial surface effect on red blood cells and platelets in laminar shear flow. Blood 1990; 75: 1568-75
29. Israels SJ, Cheang T, McMillan-Ward EM, Cheang M. Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr 2001; 138: 116-9